• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活素 A 有助于定义 t(12;21) 白血病前骨髓中的致癌微环境。

Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia.

机构信息

Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.

Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy; Clinica Pediatrica Ospedale S. Gerardo, Fondazione MBBM, University of Milano-Bicocca, Monza, Italy.

出版信息

Exp Hematol. 2019 May;73:7-12.e4. doi: 10.1016/j.exphem.2019.02.006. Epub 2019 Feb 28.

DOI:10.1016/j.exphem.2019.02.006
PMID:30825516
Abstract

The TEL-AML1 fusion gene, generated by the t(12;21) chromosome translocation, arises in a progenitor/stem cell and could induce clonal expansion of a persistent preleukemic B-cell clone which, on acquisition of secondary alterations, may turn into full-blown leukemia. During infections, deregulated cytokine signaling, including transforming growth factor β (TGF-β), can further accelerate this process by creating a protumoral bone marrow (BM) microenvironment. Here, we show that activin A, a member of the TGF-β family induced under inflammatory conditions, inhibits the proliferation of normal progenitor B cells but not that of preleukemic TEL-AML1-positive clones, thereby providing a selective advantage to the latter. Finally, we find that activin A inhibits BM-derived mesenchymal stromal cell-mediated secretion of CXCL12, a major chemoattractant in the BM compartment, thereby contributing to shape a leukemia-promoting environment. Overall, our findings indicate that activin A, in concert with TGF-β, could play an important role in the creation of a pro-oncogenic BM microenvironment and provide novel mechanistic insights into TEL-AML1-associated leukemogenesis.

摘要

TEL-AML1 融合基因由 t(12;21)染色体易位产生,源于祖细胞/干细胞,并可能诱导持续存在的白血病前 B 细胞克隆的克隆扩增,这些克隆在获得继发性改变后,可能会发展为完全成熟的白血病。在感染过程中,包括转化生长因子-β(TGF-β)在内的失调细胞因子信号可以通过创建促肿瘤性骨髓(BM)微环境进一步加速这一过程。在这里,我们表明,激活素 A,一种在炎症条件下诱导产生的 TGF-β 家族成员,抑制正常祖细胞 B 细胞的增殖,但不抑制白血病前 TEL-AML1 阳性克隆的增殖,从而为后者提供选择性优势。最后,我们发现激活素 A 抑制 BM 来源的间充质基质细胞介导的 CXCL12 的分泌,CXCL12 是 BM 隔室中的主要趋化因子,从而有助于形成促进白血病的环境。总的来说,我们的研究结果表明,激活素 A 与 TGF-β 一起,可能在创建促癌性 BM 微环境中发挥重要作用,并为 TEL-AML1 相关白血病发生提供新的机制见解。

相似文献

1
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia.激活素 A 有助于定义 t(12;21) 白血病前骨髓中的致癌微环境。
Exp Hematol. 2019 May;73:7-12.e4. doi: 10.1016/j.exphem.2019.02.006. Epub 2019 Feb 28.
2
The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.AML1基因:一种参与髓系和淋巴系白血病发病机制的转录因子。
Haematologica. 1997 May-Jun;82(3):364-70.
3
Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.在小鼠模型中定义TEL/AML1(ETV6/RUNX1)融合蛋白的致癌功能。
Oncogene. 2005 Nov 17;24(51):7579-91. doi: 10.1038/sj.onc.1208931.
4
The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.TEL-AML1白血病融合基因在早期B系祖细胞中失调转化生长因子-β信号通路。
J Clin Invest. 2009 Apr;119(4):826-36. doi: 10.1172/JCI36428. Epub 2009 Mar 16.
5
ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.ETV6-RUNX1 与 SPIB 内含子 1 中的一个区域相互作用,调节前 B 细胞急性淋巴细胞白血病中的基因表达。
Exp Hematol. 2019 May;73:50-63.e2. doi: 10.1016/j.exphem.2019.03.004. Epub 2019 Apr 12.
6
Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice.小鼠中t(12;21) TEL-AML1易位首次打击功能的建模。
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8443-8. doi: 10.1073/pnas.0402063101. Epub 2004 May 20.
7
Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.TEL/AML1阳性急性淋巴细胞白血病复发时的间期荧光原位杂交——额外的TEL和AML1拷贝数变化的临床相关性分析
Eur J Haematol. 2009 Nov;83(5):420-32. doi: 10.1111/j.1600-0609.2009.01315.x. Epub 2009 Jul 6.
8
Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region.对来自巴基斯坦不同地区的167名儿童急性淋巴细胞白血病患者进行的分子遗传学研究证实,该地区不发达国家中预后良好的融合致癌基因TEL-AML1(t(12;21))的频率较低。
Asian Pac J Cancer Prev. 2014;15(8):3541-6. doi: 10.7314/apjcp.2014.15.8.3541.
9
AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia.AML1-ETO需要一个伙伴:对t(8;21)白血病发病机制的新见解。
Cell Cycle. 2005 Dec;4(12):1716-8. doi: 10.4161/cc.4.12.2256. Epub 2005 Dec 14.
10
STAT3 mediates oncogenic addiction to TEL-AML1 in t(12;21) acute lymphoblastic leukemia.STAT3 介导 TEL-AML1 在 t(12;21) 急性淋巴细胞白血病中的致癌性依赖。
Blood. 2013 Jul 25;122(4):542-9. doi: 10.1182/blood-2012-11-465252. Epub 2013 Jun 5.

引用本文的文献

1
Chromosomal abnormalities of mesenchymal stromal cells in hematological malignancies.血液系统恶性肿瘤中间充质基质细胞的染色体异常。
Oncogene. 2025 Aug 14. doi: 10.1038/s41388-025-03528-4.
2
Development of a 3D ex vivo model of brain-leukemia interaction to study the role of activin A in the central nervous system microenvironment.开发一种脑-白血病相互作用的三维体外模型,以研究激活素A在中枢神经系统微环境中的作用。
Sci Rep. 2025 May 29;15(1):18915. doi: 10.1038/s41598-025-03877-w.
3
S100P is a core gene for diagnosing and predicting the prognosis of sepsis.
S100P是用于诊断和预测脓毒症预后的核心基因。
Sci Rep. 2025 Feb 25;15(1):6718. doi: 10.1038/s41598-025-90858-8.
4
Harnessing the power of proteins in modulation of miRNAs for targeting Iron deficiency Anemia: Opinion for future implications and strategies.利用蛋白质在调节微小RNA以靶向缺铁性贫血方面的作用:对未来影响和策略的见解
Front Nutr. 2025 Jan 27;12:1535498. doi: 10.3389/fnut.2025.1535498. eCollection 2025.
5
Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics.TIME 在 BCP-ALL 中的作用:开辟新治疗方法的基础。
Front Immunol. 2024 Jan 17;14:1325255. doi: 10.3389/fimmu.2023.1325255. eCollection 2023.
6
Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.免疫应激抑制前白血病前体 B 细胞中的先天免疫信号传导,从而在易患小鼠中引发白血病。
Nat Commun. 2023 Aug 24;14(1):5159. doi: 10.1038/s41467-023-40961-z.
7
Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche.间充质基质细胞(MSCs):骨髓造血微环境中B细胞急性淋巴细胞白血病(B-ALL)细胞疾病维持和进展的盟友。
Cancers (Basel). 2022 Jul 6;14(14):3303. doi: 10.3390/cancers14143303.
8
In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression.正常和白血病骨髓龛的体外和体内建模:细胞衰老对白血病诱导和进展的贡献。
Int J Mol Sci. 2022 Jul 1;23(13):7350. doi: 10.3390/ijms23137350.
9
The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.骨髓微环境在 B 细胞急性淋巴细胞白血病中的作用:从白血病前期到显性白血病的微环境作用。
Int J Mol Sci. 2021 Apr 23;22(9):4426. doi: 10.3390/ijms22094426.
10
Infectious triggers and novel therapeutic opportunities in childhood B cell leukaemia.儿童 B 细胞白血病中的感染诱因和新的治疗机会。
Nat Rev Immunol. 2021 Sep;21(9):570-581. doi: 10.1038/s41577-021-00505-2. Epub 2021 Feb 8.